China’s top COVID-19 vaccine candidate showed weak results among older Phase II test subjects

China’s CanSino Biologics reported preliminary results of its Phase II COVID-19 vaccine trial Monday, and there was promising news. But it was overshadowed by the results of the Oxford University …
( read original story …)